Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Narayan

Showing results (331-340 of 351) with videos related to

Pageof 36
Sort By:
BMC Cancer|March 22, 2017
The allosteric AKT inhibitor MK2206 shows a synergistic interaction with chemotherapy and radiotherapy in glioblastoma spheroid culturesRavi S Narayan, Carlos A Fedrigo, Eelke Brands, et al.
Cytokine|February 21, 2015
Leishmania donovani skews the CD56(+) Natural Killer T cell response during human visceral leishmaniasisSarita Kumari, Fauzia Jamal, Pushkar Shivam, et al.
Blood Cells, Molecules & Diseases|August 24, 2010
The cytosolic β-glucosidase GBA3 does not influence type 1 Gaucher disease manifestationNick Dekker, Tineke Voorn-Brouwer, Marri Verhoek, et al.
Cancer Research|April 8, 2011
Human glioma growth is controlled by microRNA-10bGalina Gabriely, Ming Yi, Ravi S Narayan, et al.
Analytical Methods : Advancing Methods and Applications|September 17, 2020
Identification, isolation and characterization of a new impurity in drug substance resulting from stress stability studiesVundavilli Jagadeesh Kumar, P Badarinadh Gupta, K Mukkanti, et al.
Molecular Cancer Therapeutics|August 1, 2025
Combined inactivation of MEK and mTOR can lead to synergistic cell death in glioblastoma models and associates with NF1-deficiency and a mesenchymal subtypeFleur M G Cornelissen, Yoran Broersma, Ravi S Narayan, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 3, 2023
NB-UVB phototherapy response of different body regions in non-segmental vitiligoVidhya S Narayan, Elnaz Alagha, Wouter Ouwerkerk, et al.
Molecular Cancer Therapeutics|August 20, 2025
Combined Inactivation of MEK and mTOR Can Lead to Synergistic Cell Death in Glioblastoma Models and Associates with NF1 Deficiency and a Mesenchymal SubtypeFleur M G Cornelissen, Yoran Broersma, Ravi S Narayan, et al.
Parasitology|November 16, 2017
Co-factor-independent phosphoglycerate mutase of Leishmania donovani modulates macrophage signalling and promotes T-cell repertoires bearing epitopes for both MHC-I and MHC-IIManish K Singh, Fauzia Jamal, Amit K Dubey, et al.
The Journal of Investigative Dermatology|August 23, 2025
Immune and biological changes during treatment in patients with non-segmental vitiligo and their relation to repigmentationWouter Ouwerkerk, Vidhya S Narayan, Saskia Chielie, et al.
Pageof 36

Showing results (331-340 of 351) with videos related to

Sort By:
Pageof 36
BMC Cancer|March 22, 2017
The allosteric AKT inhibitor MK2206 shows a synergistic interaction with chemotherapy and radiotherapy in glioblastoma spheroid culturesRavi S Narayan, Carlos A Fedrigo, Eelke Brands, et al.
Cytokine|February 21, 2015
Leishmania donovani skews the CD56(+) Natural Killer T cell response during human visceral leishmaniasisSarita Kumari, Fauzia Jamal, Pushkar Shivam, et al.
Blood Cells, Molecules & Diseases|August 24, 2010
The cytosolic β-glucosidase GBA3 does not influence type 1 Gaucher disease manifestationNick Dekker, Tineke Voorn-Brouwer, Marri Verhoek, et al.
Cancer Research|April 8, 2011
Human glioma growth is controlled by microRNA-10bGalina Gabriely, Ming Yi, Ravi S Narayan, et al.
Analytical Methods : Advancing Methods and Applications|September 17, 2020
Identification, isolation and characterization of a new impurity in drug substance resulting from stress stability studiesVundavilli Jagadeesh Kumar, P Badarinadh Gupta, K Mukkanti, et al.
Molecular Cancer Therapeutics|August 1, 2025
Combined inactivation of MEK and mTOR can lead to synergistic cell death in glioblastoma models and associates with NF1-deficiency and a mesenchymal subtypeFleur M G Cornelissen, Yoran Broersma, Ravi S Narayan, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 3, 2023
NB-UVB phototherapy response of different body regions in non-segmental vitiligoVidhya S Narayan, Elnaz Alagha, Wouter Ouwerkerk, et al.
Molecular Cancer Therapeutics|August 20, 2025
Combined Inactivation of MEK and mTOR Can Lead to Synergistic Cell Death in Glioblastoma Models and Associates with NF1 Deficiency and a Mesenchymal SubtypeFleur M G Cornelissen, Yoran Broersma, Ravi S Narayan, et al.
Parasitology|November 16, 2017
Co-factor-independent phosphoglycerate mutase of Leishmania donovani modulates macrophage signalling and promotes T-cell repertoires bearing epitopes for both MHC-I and MHC-IIManish K Singh, Fauzia Jamal, Amit K Dubey, et al.
The Journal of Investigative Dermatology|August 23, 2025
Immune and biological changes during treatment in patients with non-segmental vitiligo and their relation to repigmentationWouter Ouwerkerk, Vidhya S Narayan, Saskia Chielie, et al.
Pageof 36